We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Pressure Clamp Stops Hemorrhages on the Spot

By HospiMedica International staff writers
Posted on 01 Apr 2013
An innovative wound closure-clamping device controls severe bleeding within seconds of a traumatic injury. More...


The iTClamp Hemorrhage Control System is designed to save lives in prehospital trauma care environments, focusing on the control of massive hemorrhage—a leading cause of death in traumatic injury—by controlling critical bleeding in seconds. The iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The five cm long device, which resembles a hair clip, can be applied in a matter of seconds, and can be used by basically anyone with minimal training.

The sterile, plastic clamp has curved needles along the “jaws” of the device; in a trauma situation, the responder clamps the device along the wound. The curved needles and the shape of the ITClamp draw the wound up into the device and anchor it with even pressure, allowing the blood underneath to create a clot around the wound and stop the bleeding until the victim receives further medical attention; bigger wounds take more devices. The iTClamp Hemorrhage Control System is a product of iTraumaCare (San Antonio, TX, USA), and has received the European Union CE marking of Approval.

“I was inspired by the difficult conditions army medics work under; I saw the tools they had were inadequate to treat really simple problems, like bleeding,” said iTClamp developer Dennis Filips, MD, CEO of iTraumaCare, who served for 20 years as a US military trauma surgeon. “If you can get an injured person to the hospital, there’s a 98% chance they’ll survive. The big gap is the time it takes to get from the scene of the injury to the hospital.”

Related Links:

iTraumaCare



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.